Angel Biotechnology reported stronger revenues in H1 2009 compared to 2008. Revenues grew 25% and the company signed contracts worth £2.2m in the half year ended 30 June. However, losses for the six-months also increased.
InvestEgate
Friday 18 September 2009
Angel sales increase in H1
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment